Literature DB >> 16338174

The peripheral GABAergic system as a target in endocrine disorders.

A Gladkevich1, J Korf, V P Hakobyan, K V Melkonyan.   

Abstract

In addition to its well-recognized function as a cerebral inhibitory transmitter, less well established is the role of GABA in peripheral nervous and endocrine systems. We summarize current evidence that GABA serves as a neurotransmitter or neuromodulator in the autonomic nervous system and as a hormone or trophic factor in non-neuronal peripheral tissue as well. GABA is widely distributed in endocrine tissues including the pituitary, pancreas, adrenal glands, uterus, ovaries, placenta and testis. Moreover, GABA is involved in the pathophysiology of endocrine disorders such as diabetes mellitus, diseases of adrenal glands and reproductive tracts. Current literature indicates that the peripheral GABA system in the autonomic nervous system, endocrine and immune systems is as yet nearly an unexplored target for diagnosis and drug treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338174     DOI: 10.1016/j.autneu.2005.11.002

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  36 in total

1.  Distribution and quantitative detection of GABAA receptor in Carassius auratus gibelio.

Authors:  Jiming Ruan; Kun Hu; Haixin Zhang; Yi Wang; Ailing Zhou; Yini Zhao; Xianle Yang
Journal:  Fish Physiol Biochem       Date:  2014-04-01       Impact factor: 2.794

Review 2.  Neuroimmune Communication in Health and Disease.

Authors:  Colin Reardon; Kaitlin Murray; Alan E Lomax
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

3.  Determination of GABA(Aα1) and GABA (B1) receptor subunits expression in tissues of gilts during the late gestation.

Authors:  Zhiyong Fan; Yonghui Chen; Junjun Wang; Jinping Deng; Dexing Hou; Tiejun Li; Lingyuan Yang; Zhonghua Liu; Xiaosong Wu
Journal:  Mol Biol Rep       Date:  2012-10-21       Impact factor: 2.316

4.  Molecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairs.

Authors:  Ingo Vogt; Jeanette Prinz; Mónica Campillos
Journal:  Genome Med       Date:  2014-08-17       Impact factor: 11.117

Review 5.  Neurotransmitter receptors as central regulators of pancreatic cancer.

Authors:  Hildegard M Schuller; Hussein An Al-Wadei
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

6.  Role of GABAergic activity of sodium valproate against ischemia-reperfusion-induced acute kidney injury in rats.

Authors:  Ramanpreet Brar; Jaswinder Pal Singh; Tajpreet Kaur; Saroj Arora; Amrit Pal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-10-24       Impact factor: 3.000

7.  Maternally derived hormones, neurosteroids and the development of behaviour.

Authors:  James C Mouton; Renée A Duckworth
Journal:  Proc Biol Sci       Date:  2021-01-27       Impact factor: 5.349

8.  GABA B receptor is a novel drug target for pancreatic cancer.

Authors:  Hildegard M Schuller; Hussein A N Al-Wadei; Mourad Majidi
Journal:  Cancer       Date:  2008-02-15       Impact factor: 6.860

9.  Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid.

Authors:  Hussein A N Al-Wadei; Howard K Plummer; Hildegard M Schuller
Journal:  Carcinogenesis       Date:  2009-01-08       Impact factor: 4.944

Review 10.  GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches.

Authors:  Stephanie Z Young; Angélique Bordey
Journal:  Physiology (Bethesda)       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.